BIO-key International is trading 7.19% lower at $2.65, with no verified company-specific announcement explaining the decline on October 27. - The latest company release found was the October 22 Middle East government contract announcement; it does not establish a cause for today’s move. - The broad market was mixed rather than sharply lower, offering no clear explanation. - Shares fell 15.93% on October 26 after a sharp October 23 gain, but that pattern alone does not identify a catalyst.